Omnicell (OMCL) | Stock Overview & Key Data
Omnicell Performance Comparison
Stock Range
Today's Range
Low: $30.32
High: $31.00
on August 8, 2025
52 Week Range
Low: $22.66
High: $55.75
on May 6, 2025
on October 30, 2024
All-Time High: $187.29 on November 22, 2021
Explore how other US stocks compare to their 52-week ranges: View US Market 52-Week Insights
Key Statistics
Market Cap
$1.4B
EPS
0.50
P/E Ratio (TTM)
61.66
Forward P/E
17.13
P/B Ratio
1.13
PEG Ratio
17.13
Div. Yield
N/A
ROE
1.87%
Beta
0.777
Debt to Equity
30.42
Financial Highlights
Profitability
Gross Margin
43.94%
Operating Margin
2.80%
Profit Margin
2.01%
Returns and Earnings
Return on Assets (TTM)
0.49%
Return on Equity (TTM)
1.87%
EBITDA
$102.7M
Net Income (TTM)
$23.1M
Growth
Revenue (TTM)
Revenue Per Share (TTM)
$24.78
Quarterly Revenue Growth (YoY)
5.00%
Quarterly Earnings Growth (YoY)
51.00%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Omnicell OMCL | 1.43B Small-cap | 3.60% | 3.94% | 21.43% | -27.29% | -30.44% | -24.53% | -71.93% | -56.14% |
| Veeva Systems VEEV | 46.10B Large-cap | 0.28% | 0.53% | 17.78% | 18.64% | 33.98% | 50.99% | 25.19% | 9.21% |
| Ge Healthcare GEHC | 31.94B Large-cap | 3.08% | -4.26% | 2.13% | -17.71% | -8.14% | -13.67% | 26.89% | 26.89% |
| Premier PINC | 1.93B Small-cap | 9.69% | 6.43% | 0.13% | 25.63% | 9.17% | 16.77% | -39.29% | -37.03% |
| Certara CERT | 1.83B Small-cap | 14.68% | -4.04% | -7.83% | -21.86% | 2.63% | -12.39% | -37.59% | -71.22% |
| 10x Genomics TXG | 1.56B Small-cap | -6.04% | 0.33% | 42.41% | 1.91% | -13.39% | -39.84% | -74.52% | -88.03% |
Ownership & Short Interest
Insider Ownership
1.81%
Institutional Ownership
105.45%
Shares Short
2M
Short Ratio
4.36
Short % of Shares Outstanding
5.83%
Average 10-Day Volume
654K
Average 90-Day Volume
520K
Omnicell Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Omnicell would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is OMCL's 52-week high and low?
- In the last 52 weeks, Omnicell reached a high of $55.75 (on October 30, 2024) and a low of $22.66 (on May 6, 2025).
- What is the market cap and P/E ratio for OMCL?
- Curious about Omnicell's size and valuation? Its market capitalization stands at 1.43B. When it comes to valuation, the P/E ratio (trailing twelve months) is 61.66, and the forward P/E (looking ahead) is 17.13.
- Does OMCL pay dividends? If so, what's the yield?
- As for dividends, Omnicell isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Omnicell's main competitors or similar companies to consider before investing?
When looking at Omnicell, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Veeva Systems
VEEV46.10B Healthcare Health Information Services 50.99% 25.19% Ge Healthcare
GEHC31.94B Healthcare Health Information Services -13.67% 26.89% Premier
PINC1.93B Healthcare Health Information Services 16.77% -39.29% Certara
CERT1.83B Healthcare Health Information Services -12.39% -37.59% 10x Genomics
TXG1.56B Healthcare Health Information Services -39.84% -74.52% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Omnicell Inc.? (e.g., ROE, Debt/Equity)
- To get a sense of Omnicell's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 1.87%, the Debt to Equity ratio from the most recent quarter is 30.42, and its Gross Profit Margin stands at 43.94%.
- What is the recent revenue and earnings growth for OMCL?
- Looking at Omnicell's growth, its revenue over the trailing twelve months (TTM) was $1B. Compared to the same quarter last year (YoY), quarterly revenue grew by 5.00%, and quarterly earnings saw a YoY growth of 51.00%.
- How much of OMCL stock is held by insiders and institutions?
- Wondering who owns Omnicell stock? Company insiders (like executives and directors) hold about 1.81% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 105.45%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.